
Company Information
Ask for more detail from the seller
Contact SupplierCabazirix 60 mg Injection contains cabazitaxel, a microtubule inhibitor used in combination with prednisone to treat metastatic castration-resistant prostate cancer (mCRPC) in patients previously treated with a docetaxel-containing regimen. Cabazitaxel works by binding to tubulin, promoting its assembly into microtubules while inhibiting their disassembly, leading to stabilization of microtubules and inhibition of mitotic and interphase cellular functions, thereby preventing cancer cell division and growth.